New, late-breaking data at EADV highlights emerging clinical profile of amlitelimab (formerly KY1005) in adults with inadequately controlled moderate-to-severe atopic...
Topical roflumilast provided significant improvements in severity and burden of itch in Phase 3 plaque psoriasis studies, as well as...
Notice of Allowance Issued for “Method for Reducing Post-Operative Cognitive Dysfunction (POCD)”PALO ALTO, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) --...
Company to Request Pre-NDA Meeting with U.S. Food and Drug Administration Figure 1 Comparisons of AUCinf and Cmax between Phase...
WORCESTER, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
This financial calendar lists the expected dates of publication of financial announcements and the Annual General Meeting for the financial...
WALTHAM, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for...
PURCHASE, NY, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, ranks...
ORANGE, Calif., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced the addition of...
Expands Board of Directors with Appointment of Cindy Jacobs, PhD, MD NEW YORK, Sept. 30, 2021 (GLOBE NEWSWIRE) -- HiberCell,...
AUSTIN, Texas, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a U.S. clinical-stage pharmaceutical company developing...
Survey finds 91% of people wish the world was filled with more random acts of kindness and smiles.*NASHVILLE, Tenn., Sept....
Median reduction in drop seizure frequency was 39.4% at 3 months (n= 227; p<0.0001) and 51.8% for patients assessed over...
CAMBRIDGE, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and...
Evidence Supports Use of Deep TMS as a Safe and Effective Treatment for Smoking Addiction BURLINGTON, Mass. and JERUSALEM, Sept....
CAMBRIDGE, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, will present...
Investment expected to extend Spero Therapeutics’ cash runway into 2H 2023CAMBRIDGE, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics,...
The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults...
Brings deep industry experience to support commercialization planFRAMINGHAM, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH)...
Combined ID-IGHV report at time of diagnosis conveniently provides additional prognostic information while also enabling future MRD monitoring in patientsSEATTLE,...
